* MEDESIS PHARMA *
2003 - Langeudoc-Roussillon
Baillargues
(near Montpellier)
www.medesispharma.com Discovery, Drugs
Key words: Nanotechnology drug delivery systems, Metals low doses, Vanadium, Manganese, Strontium, Metabolic syndrome, Diabetes, Huntington Disease, Bipolar Disorders
Mission: to develop new innovative treatments of diabetes and neurodegenerative disorders based on metallic ions technology and delivery of nucleic acid (siRNA antisens)
Clients: undisclosed
contact@medesispharma.com
Age: 9 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Personal venture |
Managing Dir.-CEO: Maurel (Jean-Claude) [founder, born 1946, M.D., M.Sc., ex-Natura Medica (founder)]
Sc.Dir.-CSO: Maurel (Patrick) [Ph.D., ex-Inserm]
Oper.Dir.-COO: Jackson (Peter) [Ph.D.]
Fin.Dir.-CFO:
BusDev: Jackson (Peter)
Financers (Hist.): privately owned | Turnover (M€) : 0.013 (2008), 0.085 (2007)
Total funding (M€) : 8.5
Last funding (M€) : 2.7
Focus : Multiple
Position : Clinical
Company confirm : 2-May-2011 |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2011 .06 | Clinical trial (phase IIa) for NP03 in bipolar disorders (beginning) | CLIN | [8 years] |
| 2011 .01 | Clinical trial (phase I) for disease modifying treatment for Huntington’s disease NP03 (completed) | CLIN | [7 years] |
| 2010 .05 | Clinical trial (phase I) for anti-diabetic NP01 (completed) | CLIN | [7 years] |
| 2009 .12 | Registration : orphan Drug positive opinion by EMEA for treatment of Huntington's disease (NP03) | MKTG | [6 years] |
| 2008 .04 | Financing (no interest loan) : 0.9 M€, by OSEO and Languedoc-Roussillon region, to support its ongoing program for NP01 in diabetes | DEBT | [5 years] |
| 2008 .01 | Company move from Paris to Baillargues (10km from Montpellier) | ORGL | [4 years] |
| 2006 .01 | Clinical trial planned, after first preclinical trial results on NP01 on metabolic syndrome | CLIN | [2 years] |
| 2003 .04 | Company founded by Jean-Claude Maurel, headquartered in Baillargues (today : labs location) | ORGF | [0 year] | Actualisation / Updating: 28-Sep-2011 |
|
